Clinical, ultrasonographical and hormonal correlation in women with polycystic ovarian syndrome
Keywords:Free testosterone, Hirsutism, Hyperandrogenesim, PCOS, Polycystic ovaries, Ultrasound
Background: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of fertile age. The prevalence, time of onset and severity of clinical presentation vary among different ethnic and racial groups. Though there is significant reproductive, endocrine and metabolic morbidity of PCOS, very little is known about its different modes of presentation in Indian population. It is a cross sectional observational study. The objective To study the correlation between the clinical, ultrasonographical and hormonal features in women diagnosed as PCOS based on the revised diagnostic criteria, 2003.
Methods: A cross-sectional study of 74 PCOS women who had oligo ovulatory cycles and polycystic ovarian morphology on ultrasound was done. Data about menstrual history and anthropometric measurements were collected. Clinical observations of acne and hirsutism were made. Transvaginal ultrasonography and biochemical analysis for free testosterone was done.
Results: In all, 74 PCOS women were studied and analyzed. The mean age was 24.88±4.03, mean BMI was 25.48 ±3.75 and mean free testosterone was 3.81±4.05. Among the PCOS women 39.8% were hirsute, 10.1% were obese, 2.3% had acne and 38% were hyperandrogenemic. Of the hyperandrogenemic women 61.2% were hirsute, 53.22% were obese and 36.54% had acne. The association between BMI and free testosterone level was statistically significant (p=0.0023). BMI was moderately correlated with hyperandrogenemia (r=0.446). The mean left ovarian volume was higher in obese than in non-obese women, which was statistically significant (p=0.003). The mean left ovarian volume was high in hyperandrogenemic women which was statistically significant (p=0.00034).
Conclusions: In the present study it was found that there is association between obesity and free testosterone level which was significant. There was statistically significant association between ovarian volume and obesity. Similarly, there was association between ovarian volume and hyperandrogenemia which was significant. Hirsutism and acne had no association with hyperandrogenemia.
Franks S. Polycystic ovary syndrome. New England J. Med. 1995;333(13);853-61.
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998; 83(9):3078-82.
Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84(11):4006–11.
Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999; 51(6):779-86.
Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434-8.
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clini Endocrinol Metabol 2004; 89(6):2745-9.
Leven JS, Imani B, Eijkemans MJ, Fauser BC. New approaches to PCOS and other forms of anovulation. Obstet Gynecol Surv. 2002;57(11):755-67.
Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002;77(6):1095-105.
Wild RA. Long-term health consequences of PCOS. Hum Reprod Update 2002;8(3):231-41.
Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24(3):302-12.
Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003; 361(9389):1810-2.
Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rationale approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds, Polycystic ovary syndrome. Boston: Blackwell Scientific Publications: 1992: 377-84.
Balen AH, Conway, GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduct. 1995;10(8):2107-11.
Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound feature in 556 patients. Clinical Endocrinol 1989;30(4):459-70.
Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diaanosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril. 1997;67(3):452-8.
Slowey MJ. Polycystic ovary syndrome : New perspective on an old problem. South Med J. 2001; 94(2):190-6.
Franks S. Polycystic ovary syndrome: a changing perspective (review). Clin Endocrinol. 1989;31(1): 87-120.
Carmina E, Lobo RA. Polycystic ovaries in hirsute women with normal menses. Am J Med 2001;111(8):602-06.
The Rotterdam ESHRE/ ASRM- sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reproduction 2004;19(81):41-7.
Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Brit Med J 1986; 293(6543):355-9.
Clinical Management guidelines for Obstetrician – Gynecologists. Polycystic ovary syndrome. ACOG Practice Bulletin, No. 41, 2002.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J clin Endocrinol Metab 1961;21(11):1440.
Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism : Implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815.
Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endorinol Metab. 1986;15(2):259-78.
Wu CH. Plasma free and protein. bound testosterone in hirsutism. Obstet Gynecol. 1982; 60(2):188-94.
Oka K, Hirano T, Noguchi M. Changes in the concentration of testosterone in serum during menstrual cycle, as determined by liquid chromatography. Clin Chem. 1988;34(3):557-560.
Bhattacharya D, Mandal SK, Mukherjee S, Pradhan M. Clinical correlation with biochemical status in polycystic ovarian syndrome. J Obstet Gynecol Indian. 2005;55(1):67-71.
Penttila TA, Koskinen P, Anttila L, Erkkola R, Torma A, Irjala K. Serum free testosterone in polycystic ovary syndrome measured with a new reference method. Fertil Steril. 1996;65(1):55-60.
Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case–control study. Arch Gynecol Obstet. 2013;287(3):525-31.
Vanky E, Kjotrod S, Salvesen KA, Romundstad P, Moen MH, Carlsen SM. Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS. Acta Obstet Gynecol Scand 2004;83(5):482-6.
Hamilton JB, Terada H. Interdependence of genetic, aging, and endocrine factors in hirsutism. The Hirsute Female. 1963:20-47.
Leerasiri P, Wongwananuruk T, Indhavivadhana S, Techatraisak K, Rattanachaiyanont M, Angsuwathana S. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome. J. Obstet. Gynaecol. 2016;42(6):678-83.
Lobo RA, Goebelsmann U, Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J. Clin Endocrinol Metabol. 1983;57(2): 393-7.
Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson. Pelvic ultrasound measurements in normal girls. Acta Paediatr. 1995;84(5):536-43.
Christensen JT, Boldsen J, Westgaard JG. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand. 1997;76(8):784-9.